[1] | Jessica, J.F., Ingrid, E.S., Robert, S.F, “The new definition and classification of seizures and epilepsy,” Epilepsy Research, 139. 73-79. 2018. |
|
[2] | Panayiotopoulos, C.P, Syndromes of idiopathic generalized epilepsies not recognized by the International League against Epilepsy. Epilepsia, 2005, 46. 57-66. |
|
[3] | Schmidt, D. and Loscher, W, “Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms,” Epilepsia, 46 (6). 858-877. 2005. |
|
[4] | Boonluksiri, P., Visuthibhan, A. and Katanyuwong, K, “Clinical Prediction Rule of Drug Resistant Epilepsy in Children,” Journal of epilepsy research, 5(2). 84-88. 2015. |
|
[5] | Siddiqui, A., Kerb, R., Weale, ME., Brinkmann, U., Smith, A., Goldstein, D.B., Wood, N.W. and Sisodiya, S.M, “Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1,” New England Journal of Medicine, 348(15). 1442-1448. 2003. |
|
[6] | Manna, J. and Sanjeev, T, “Role of multidrug transporters in neurotheraputics,” Annals of Indian Academy of Neurology, 12(2). 89-98. 2009. |
|
[7] | Komar, A.A, “Silent SNPs: impact on gene function and phenotype,” Pharmacogenomics, 8(8). 1075-1080. 2007. |
|
[8] | Kwan, P., Arzimanoglou, A., Berg, A., Brodie, M., Hauser, W., Mathern, G., Perucca, S., Wiebe, S. and French, J, “Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies,” Epilepsia, 51(6).1069-1077. 2010. |
|
[9] | Morisky, D.E., Green, L.W. and Levine, D.M, “Concurrent and predictive validity of a self-reported measure of medication adherence,” Medical Care, 24. 67-74. 1986. |
|
[10] | Emich-Widera, E., Likus, W., Kazek, B., Sieroń, A. and Urbanek, K, “Polymorphism of ABCB1/MDR1 C3435T in Children and Adolescents with Partial Epilepsy is due to Different Criteria for Drug Resistance – Preliminary Results,” Medical Science Monitor, 20. 1654-1661. 2014. |
|
[11] | Zimprich, F., Sunder-Plassmann R., Stogmann, E., Gleiss, A., Dal-Bianco , A., Zimprich, A., Plumer, S., Baumgartner, C. and Mannhalter, C, “Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy,” Neurology, 63.1087-1089. 2004. |
|
[12] | Hung, C.C., Tai, J.J., Lin, C.J., Lee, M.J. and Liou, H.H, “Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response,” Pharmacogenomics, 6. 411-417. 2005. |
|
[13] | Ebid, A.H., Ahmed, M.M. and Mohammed, S.A,”Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study,” Therapeutic Drug Monitoring, 29(3). 305-312. 2007. |
|
[14] | Dericioglu, N., Babaoglu, M.O., Yasar, U., Bal, I.B., Bozkurt, A. and Saygi, S, “Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene,” Epilepsy Research, 80. 42-46. 2008. |
|
[15] | Ozgon, G.O., Bebek, N., Gul, G. and Cine, N, “Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey,” European Neurology, 59(1-2). 67-70. 2008. |
|
[16] | Shahwana, A., Murphya, K., Dohertyc, C., Cavalleri, G., Muckiane, C., Dickere, P., McCarthya, M., Kinironsa, P., Goldsteind, D. and Delantya, N, “The controversial association of ABCB1 polymorphisms in refractory epilepsy: An analysis of multiple SNPs in an Irish population,” Epilepsy Research, 73. 192-198. 2007. |
|
[17] | Kim, D.W., Kim, M., Lee, S.K., Kang, R. and Lee, S.Y, “Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy,” Seizure, 15. 344-347. 2006. |
|
[18] | Seo, T., Ishitsu, T., Ueda, N., Nakada, N., Yurube, K., Ueda, K. and Nakagawa, K, “ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients,” Pharmacogenomics, 7(4). 551-561. 2006. |
|
[19] | Ponnala, S., Chaudhari, J.R., Jaleel, M.A., Bhiladvala, D., Kaipa, P.R., Das, U.N. and Hasan, Q, “Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on antiepileptic drug (phenytoin) absorption,” Genetic Testing and Molecular Biomarkers, 16. 550-557. 2012. |
|
[20] | Shaheen, U., Prasad, D.K., Sharma, V., Suryaprabha, T., Ahuja, Y.R., Jyothy, A. and Munshi, A, “Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy,” Epilepsy Research, 108(2). 251-256. 2013 |
|
[21] | Sayyah, M., Kamgarpour, F., Maleki, M., Karimipoor, M., Gharagozli, K. and Shamshiri, A.R, “Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients,” Epileptic Disorder, 13(2). 155-165. 2011. |
|